Page last updated: 2024-08-24

plerixafor and MS (Multiple Sclerosis)

plerixafor has been researched along with MS (Multiple Sclerosis) in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daniels, BP; Klein, RS; Patel, JR; Williams, JL1
Flügel, A; Miljković, D; Momcilović, M; Mostarica-Stojković, M; Odoardi, F; Stanojević, Z1

Other Studies

2 other study(ies) available for plerixafor and MS (Multiple Sclerosis)

ArticleYear
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
    The Journal of experimental medicine, 2014, May-05, Volume: 211, Issue:5

    Topics: Analysis of Variance; Animals; Axons; Benzylamines; Blotting, Western; Bromodeoxyuridine; Central Nervous System; Cyclams; Heterocyclic Compounds; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Real-Time Polymerase Chain Reaction; Receptors, CXCR; Receptors, CXCR4; Stem Cells

2014
CXCL12 expression within the CNS contributes to the resistance against experimental autoimmune encephalomyelitis in Albino Oxford rats.
    Immunobiology, 2011, Volume: 216, Issue:9

    Topics: Animals; Benzylamines; CD11b Antigen; CD4 Antigens; Chemokine CXCL12; Cyclams; Encephalomyelitis, Autoimmune, Experimental; Freund's Adjuvant; Gene Expression; Heterocyclic Compounds; Immunization; Interferon-gamma; Interleukin-17; Multiple Sclerosis; Rats; Rats, Inbred Strains; Species Specificity; Spinal Cord; T-Lymphocytes; Tissue Extracts

2011
chemdatabank.com